Literature DB >> 10794793

Contact lens electroretinography in preterm infants from 32 weeks after conception: a development in current methodology.

H Mactier1, R Hamilton, M S Bradnam, T L Turner, J Dudgeon.   

Abstract

AIM: To assess the feasibility of using a contact lens electrode to record the electroretinogram (ERG) in preterm infants less than 35 weeks after conception.
METHODS: The ERG was recorded from seven very low birthweight preterm infants on a total of 14 occasions using an infant monkey contact lens electrode. Age at recording the first ERG ranged from 23 to 51 days (gestational age 32-34 weeks), and weight ranged upwards from 1100 g.
RESULTS: No complications were observed. With advancing age and maturity the dark adapted rod threshold decreased, indicating increased retinal sensitivity.
CONCLUSIONS: Contact lens recording of the ERG from extremely small immature preterm infants is a practicable and well tolerated procedure. This method of recording the ERG will enable further evaluation of retinal development in this vulnerable population.

Entities:  

Mesh:

Year:  2000        PMID: 10794793      PMCID: PMC1721095          DOI: 10.1136/fn.82.3.f233

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  17 in total

1.  The ERG of premature and full-term born infants during their first days of life.

Authors:  J E WINKELMAN; G P HORSTEN
Journal:  Ophthalmologica       Date:  1962       Impact factor: 3.250

2.  Light reduction and the electroretinogram of preterm infants.

Authors:  K A Kennedy; M A Ipson; D G Birch; J E Tyson; J L Anderson; S Nusinowitz; L West; R Spencer; E E Birch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

3.  Photoreceptor function in infants and children with a history of mild retinopathy of prematurity.

Authors:  A B Fulton; R M Hansen
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  1996-03       Impact factor: 2.129

4.  Maturation of electroretinograms and visual evoked potentials in preterm infants.

Authors:  A A Leaf; C R Green; A Esack; K L Costeloe; P F Prior
Journal:  Dev Med Child Neurol       Date:  1995-09       Impact factor: 5.449

5.  Postnatal retinal development as measured by the electroretinogram in premature infants.

Authors:  M B Mets; V C Smith; J Pokorny; A Pass
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

6.  A personal computer-based visual evoked potential stimulus and recording system.

Authors:  M S Bradnam; A L Evans; D M Montgomery; D Keating; B E Damato; A Cluckie; D Allan
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

7.  The rod sensitivity of dark adapted human infants.

Authors:  A B Fulton; R M Hansen
Journal:  Curr Eye Res       Date:  1992-12       Impact factor: 2.424

8.  Quantitative assessment of the blue-light hazard during indirect ophthalmoscopy and the increase in the "safe" operating period achieved using a yellow lens.

Authors:  M S Bradnam; D M Montgomery; H Moseley; G N Dutton
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

View more
  4 in total

1.  Standard full-field electroretinography in healthy preterm infants.

Authors:  Adriana Berezovsky; Nilva Simeren Bueno Moraes; Steven Nusinowitz; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2003-11       Impact factor: 2.379

2.  Comparison of electroretinogram between healthy preterm and term infants.

Authors:  Xiaohong Zhou; Xin Huang; Hongling Chen; Peiquan Zhao
Journal:  Doc Ophthalmol       Date:  2010-09-28       Impact factor: 2.379

Review 3.  Vitamin A and preterm infants: what we know, what we don't know, and what we need to know.

Authors:  H Mactier; L T Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

Review 4.  Retinogenesis of the Human Fetal Retina: An Apical Polarity Perspective.

Authors:  Peter M J Quinn; Jan Wijnholds
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.